Skip to main content
Clinical Trials/ACTRN12620000732987
ACTRN12620000732987
Not yet recruiting
Phase 4

Effectiveness of intra-articular hyaluronic acid compared to corticosteroid or placebo injections to treat basal thumb osteoarthritis: a prospective, randomised, blinded clinical study

Prof. Warren Rozen0 sites90 target enrollmentJuly 13, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof. Warren Rozen
Enrollment
90
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 13, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof. Warren Rozen

Eligibility Criteria

Inclusion Criteria

  • Participants eligible for the trial must comply with all of the following at randomization:
  • 1\.Age greater or equal to 40 years
  • 2\.Symptomatic 1st carpometacarpal osteoarthritis requiring non\-operative treatment, diagnosed by both standard clinical and radiographic measures as below
  • a.Clinical osteoarthritis includes the following
  • i.History of carpometacarpal tenderness, thumb or wrist pain at rest or with activity, joint stiffness or decreased function
  • ii.Examination yielding dorsoradial prominence of the thumb metacarpal base, tenderness over the joint, crepitus, positive grind” test or positive distraction” test
  • b.Radiographic evidence of osteoarthritis of any Eaton\-Littler\-Burton classification
  • Patients who have received previous injections to the carpometacarpal joint to be treated of either hyaluronic acid or steroid will be included if they have had 1 or 2 prior injections with reported improvement in pain and function after the injections as they will be likely to have benefit from a further injection.

Exclusion Criteria

  • 1\.Prior surgery to affected thumb/wrist
  • 2\.Injury to joint in last 6 months
  • 3\.Prior or current infection in affected joint
  • 4\.History of inflammatory arthritis or skin disease at the injection site
  • 5\.Pre\-existing chondrocalcinosis, thoracic outlet syndrome, carpal tunnel syndrome, Guyon’s canal syndrome, cubital tunnel syndrome, diabetic neuropathy or cheiroarthropathy, palmar tenosynovitis, trigger thumb, fibromyalgia, pain syndrome, psoriasis
  • 6\.Pregnant or lactating women
  • 7\.Known allergy to local anaesthetic, cortisone or hyaluronic acid derivative products
  • 8\.Visual Analogue Scale \<40mm
  • 9\.Regular opiate use for a concomitant condition or analgesics unless stable dosage for over or equal to 1 month
  • 10\.If participants have had more than 2 injections of either hyaluronic acid or corticosteroid to the first carpometacarpal joint or an injection in the last 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials